Share Information. Key data per share

Transcription

1 Share Information The CompuGroup Medical share is listed on the Frankfurt Stock Exchange, Prime Standard, under the ticker COP (FRA: COP). The shares are traded through the world-wide electronic trading system XETRA. As at 31 December 2013, there were 53.2 million shares outstanding, each with a calculated value of EUR Key data per share Year-end price Year high Year low Year average 17, Yearly trade m Shares m Number of shares Shares m Market capitalization 1 m Earnings per share Dividend per share 0.35 ² Dividend payout m , ,5 12,6 Dividend yield % , ) as of ) Subject to Annual General Meeting approval 3) related to net income of CGM AG 4) as of date of approval of 2013 financial statements Share development In the fiscal year 2013, the share price increased from EUR to EUR This represents an increase of 25 percent, bringing the total market capitalization up EUR 196 million to a total of EUR 976 million at the end of the year The shares ended 2013 at EUR The high for the year was reached on 10 December 2013 with EUR The yearly trading volume increased significantly (+62 percent) to reach 8.6 million. The average daily trading volume in 2013 was approximately. 34,000 shares (previous year: approximately 21,000). The share price development during 2013 can be seen below: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Tec DAX DAX CGM 170 Annual Report 2013 CompuGroup Medical AG

2 Essence of 2013 To Our Shareholders Combined Management Report Financial Statements Additional Information CGM share included in TecDAX On 23 September 2013 the German Stock Exchange included the CGM share in the German technology stock index TecDAX which comprises the 30 largest technology stocks in the Prime Standard. Dividend In the 2013 financial year EUR 17.4 million were paid out corresponding to a dividend per share of EUR In 2013, the Management and Supervisory Board will propose the payment of a dividend of EUR 0.35 per share to the Annual General Meeting held on 14 May Subject to the shareholder s approval, the dividend amount would total EUR Based on the 2013 closing share price (EUR 18.34), this would equate to a dividend yield of 1.91 percent. Share data Listing Börse Frankfurt, Germany, Prime Standard ISIN DE WKN Xetra Trading Parameters Symbol COP Annual Report 2013 CompuGroup Medical AG 171

3 Investor Relations The Management Board and the Supervisory Board of CompuGroup Medical AG identify with the objectives of the German Corporate Governance Code of promoting responsible and transparent management and control oriented to a sustainable increase in shareholder value. Investors and capital market participants are to be provided consistent, timely and precise information simultaneously. CompuGroup Medical, as an international company with investors across the globe, publishes all news and press releases in English as well as German. The Investor Relations section of the company s corporate website is an important tool containing up-to-date information on the company s financial performance and stock market information. User may also find financial reports, an updated financial calendar, detailed company information and other important data for the financial markets. In conjunction with the release of its interim and full year financial results, CGM gives public presentations to investors, analysts and press. During the year, CompuGroup Medical held numerous physical meetings and phone calls with German and international investors and analysts and participated in international capital market conferences. The cities covered during road shows and conferences in 2013 include: Amsterdam, Boston, Frankfurt, Geneva, London, Milano, Munich, New York, Paris and Zurich. CGM also held telephone conferences and analyst meetings when publishing quarterly results. At the world s largest medical trade fair MEDICA in Düsseldorf CompuGroup Medical held an investor and analyst conference in November In addition to the publication of CGM s Q3 results, the company presented products and services from various business units. At the end of the year, the number of analysts that regularly follow CompuGroup Medical amounted to seven, all of them based in Germany. Commerzbank AG started covering the stock in June 2013, Landesbank Baden-Württemberg in November With three buy, one neutral and three hold recommendations, the analysts presented a positive view of the CompuGroup Medical share. The forecast price targets ranged from EUR to EUR at the end of Annual Report 2013 CompuGroup Medical AG

4 Essence of 2013 To Our Shareholders Combined Management Report Financial Statements Additional Information Financial Calendar 2014 Date Event 27 March 2014 Annual Report May 2014 Interim Report Q May 2014 Annual General Shareholder Meeting, Koblenz 07 August 2014 Interim Report Q November 2014 Interim Report Q / Analyst Conference Annual Report 2013 CompuGroup Medical AG 173

5 Imprint Headquarters CompuGroup Medical AG Maria Trost Koblenz Phone Represented by the Management Board: Frank Gotthardt (Chairman), Uwe Eibich, Christian B. Teig Chairman of the Supervisory Board: Prof. Dr. Klaus Steffens Registered office: Koblenz, commercial register number HRB 4358 VAT identification number: DE Investor Relations: Christian B. Teig, CFO Phone Annual Report 2013 CompuGroup Medical AG